JNJ), where a total volume of 71,067 contracts has been traded thus far today, a contract volume which is representative of approximately 7.1 million underlying shares (given that every 1 contract ...

Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

One of the best pharma stocks to add to your portfolio is Johnson & Johnson (JNJ), a blue chip healthcare company with a long history of rewarding shareholders. It boasts a strong balance sheet ...

Johnson & Johnson is scheduled to announce its earnings on Tuesday, April 15, 2025. Analysts expect earnings of $2.59 per share on revenue of $21.6 billion for the current year, compared to $2.71 ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire ...